key: cord-0838925-a793bgc1
authors: Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shan, Chao; Zhou, Yi-Wu; Shen, Xu-Rui; Li, Qian; Zhang, Lei; Zhu, Yan; Si, Hao-Rui; Wang, Qi; Min, Juan; Wang, Xi; Zhang, Wei; Li, Bei; Zhang, Hua-Jun; Baric, Ralph S.; Zhou, Peng; Yang, Xing-Lou; Shi, Zheng-Li
title: Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2
date: 2020-05-21
journal: Cell
DOI: 10.1016/j.cell.2020.05.027
sha: a610dedbfd53b30a2bc0e2ad917b2c2923b31a8c
doc_id: 838925
cord_uid: a793bgc1

Summary COVID-19 has spread worldwide since 2019 and is now a severe threat to public health. We previously identified the causative agent as a novel SARS-related coronavirus (SARS-CoV-2) that uses human angiotensin-converting enzyme 2 (hACE2) as the entry receptor. Here, we successfully developed a SARS-CoV-2 hACE2 transgenic mouse (HFH4-hACE2 in C3B6 mice) infection model. The infected mice generated typical interstitial pneumonia and pathology that were similar to those of COVID-19 patients. Viral quantification revealed the lungs as the major site of infection, although viral RNA could also be found in the eye, heart, and brain in some mice. Virus identical to SARS-CoV-2 in full-genome sequences was isolated from the infected lung and brain tissues. Lastly, we showed that pre-exposure to SARS-CoV-2 could protect mice from severe pneumonia. Our results show that the hACE2 mouse would be a valuable tool for testing potential vaccines and therapeutics.

In December 2019, a coronavirus disease (named as COVID-19 later) was reported in Wuhan 39 city, which rapidly spread throughout China and then to many other countries in the world ( showed two distinct clinical phenotypes from 4 DPI. One mouse (G-D5-M3) was found dead 4 104 DPI, and two lost weight 4 DPI and were humanely euthanized 5 DPI. The remaining mouse 105 began to lose weight 6 DPI and was humanely euthanized 7 DPI. In total, these four mice 106 showed significant body weight decreases from days 4 to 6 and generated noticeable respiratory 107 distress and neurological symptoms before death or humane euthanisation. All other mice 108 survived to the endpoint without evident symptoms (Table S1 and Figure 1B) . 109 110 White blood cells (WBC) analysis indicated that the levels of most neutrophils and monocytes 111 began to increase in the peripheral blood at day 1, peaked at day 3, and decreased 5 and 7 DPI in 112 the infected group, compared with those of control mice ( Figure S1 ). The infected mice 113 demonstrated a reduced ratio of lymphocytes 1 DPI. However, lymphocytes ratio recovered, 114 beginning on 3 DPI. All the dying mice (dead or lost >20% body weigh) showed significantly 115 decreased lymphocytes numbers, which is one of the key clinical hallmarks of COVID-19 116 patients . Five mice showed significantly higher levels of creatine kinase 117 compared with those of the control group, which may be linked to muscle fatigue, soreness, or 118 myocarditis (Table S2 ). The deceased mice showed higher aspartate transaminase and creatine 119 kinase levels than the control group. These data suggested that SARS-CoV-2-infected mice 120 generate symptoms that partly resembled human infection symptoms (Chen et To better understand viral replication in hACE2 mice, viral RNA was quantified by RT-qPCR in 153 different tissues from mice euthanized at 1, 3, 5, and 7 DPI (Figures 3A-D) . The viral nucleic 154 acid was detected in all lungs from 1 DPI, and slowly increased until 5 DPI, and then decreased 155 beginning 7 DPI ( Figure 3A ). We also found low viral RNA copies in the eyes and hearts in 156 eight and two infected mice, respectively ( Figures 3B and 3C) . No viral RNA was detected in 157 other organs. Viral antigens were detected in bronchial epithelial cells and alveolar cells of the 158 lungs using immunohistological assays with cross-reactive antibody that has been used for 159 SARS-CoV-2 detection previously (Zhou et al., 2020) ( Figure 3E) . Notably, four of the animals 160 demonstrated SARS-CoV-2 neuroinvasion of the brain, but only in the deceased mice ( Figure  161 3D). However, the exact details and mechanisms regulating SARS-CoV-2 neuroinvasion remain 162 unclear, as this phenomenon has been previously described with this mouse model (Menachery 163 et al., 2016) . We then tried to re-isolate SARS-CoV-2 from infected animals. We inoculated 164

Vero E6 cells with infected mouse (G-D7-M1) lung and brain homogenate supernatant and 165 observed a noticeable cytopathic effect (CPE) in the infected cells ( Figures S4B-C) compared 166 with the control ( Figure S4A) . The re-isolated virus from lung and brain of G-D7-M1 was 167 confirmed by indirect imunofluorescence assays (IFA) and genome sequencing ( Figures S4D-F , 168 Table S3 ). The lung isolates indicated two mutations, C14554T (nsp13, L372F) and C23525T 169 no.EPI_ISL_402124). The mutation at nsp13 was unique compared with published viral 171 sequences identified by online BLAST. The mutation in the spike gene was located at the end of 172 the S1 region of the spike gene. This mutation was identified using BLAST in SARS-CoV-2 173 genome sequence isolated from a patient from the United States (Genbank no. MT163720). The 174 brain isolates exhibited only one mutation, C23525T (H644Y), at the S1 region of the spike 175 gene. The viral titres in the infected lung ranged from 9.4×10 3 to 9.1×10 5 TCID 50 per gram of 176 tissue, as determined by serial dilution of VeroE6 cell lines ( Figure S5) . Conclusively, SARS-177

CoV-2 mainly replicated in mouse lung, although it may also target the brain, heart, and eyes of 178 with the infection group. Upon infection, three mice died 6 DPI. All the deceased mice were 188 male, with total mortality of 50% (3/6). In general, there were two infection outcomes, those that 189 lost more than 20% body weight from 4 or 5 DPI and died eventually, or those that lost less than 190 10% of body weight and survived (Figures 4B and 4C) Three mice, one male and two females who survived the infection, were observed for 21 days. 194

These mice generated antibodies against SARS-CoV-2 that could neutralise 100 TCID 50 viruses 195 at dilutions of 1:10 to 1:40 (Table S4) We also demonstrated that the lung is the primary target of this virus, although the eye, heart, 248 and brain could also be infected. In human cases, it has been suspected that SARS-CoV or 249 SARS-CoV-2 could also attack the eye, heart and brain, however, only limited data are available 250 as control (P), severely infected mice (Q) show hyaline membrane (R, green arrow) and hyaline 337 thrombus (R, black arrow). Images were collected using a Pannoramic MIDI system. Scale bar: 338 500 µm (A, B, D, E, F, J, K, L, P, Q) and 100 µm (C, G, H, I, M, N, O, R) . See also Figure S2 . surviving mice 21 DPI and three previously mock-infected mice were infected with 7*10 5 358 TCID 50 SARS-CoV-2 at 21 DPI, respectively. Body weights (A) and survival outcomes (B) were 359 monitored for up to 5 days. Mice were euthanised 5 DPI, and the viral loads were measured 360 using RT-qPCR (C). Naïve-infected mouse lung showed peri-bronchial and peri-vascular 361 infiltration and oedema with hyaline membrane formation (D). In contrast, previously challenged 362 mice presented mild peri-bronchial and peri-vascular infiltration (E). Viral antigen was widely 363 present in the naïve-infected mouse lung (F) and brain (H) but barely observed in previously 364 challenged mouse lung (G) and brain (I). Error bars indicate the standard error. ND: not 365 detected. Scale bar: 500 µm (D, E), 100 µm (F, G) and 200 µm (H, I). See also Table S3 . Infected mouse lung and brain tissues were homogenised with DMEM, and the 386 supernatant was used to infect Vero E6 cells. CPE was observed in cells infected by the

Simulation of the clinical and pathological manifestations of 519

COVID-19) in golden Syrian hamster model: implications for 520 disease pathogenesis and transmissibility

Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus 527 pneumonia in Wuhan, China: a descriptive study

Modeling pathogenesis of 529 emergent and pre-emergent human coronaviruses in mice

SARS-CoV-2 isolation from ocular secretions of a 532 patient with COVID-19 in Italy with prolonged viral RNA detection

Origin and evolution of pathogenic coronaviruses

SARS and MERS: 537 recent insights into emerging coronaviruses

Molecular determinants of severe acute 540 respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models 541 of human disease

The species Severe acute respiratory syndrome-related coronavirus: 545 classifying 2019-nCoV and naming it SARS-CoV-2

Multiple organ infection and the pathogenesis of SARS

Clinical Characteristics of Coronavirus Disease 2019 in China

SARS-CoV-2 cell entry 554 depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Functional assessment of cell entry and receptor 560 usage for SARS-CoV-2 and other lineage B betacoronaviruses

Early transmission dynamics in Wuhan, China, of novel coronavirus-563 infected pneumonia

The neuroinvasive potential of SARS-CoV2

may be at least partially responsible for the respiratory failure of COVID-19 patients

2019-nCoV transmission through the ocular surface 568 must not be ignored

Lethal infection of K18-hACE2 mice infected 571 with severe acute respiratory syndrome coronavirus

SARS-like WIV1-CoV poised 574 for human emergence

Severe acute 576 respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis 577 in mice transgenic for human ACE2

Targeting expression of a 579 transgene to the airway surface epithelium using a ciliated cell-specific promoter

A mouse-adapted SARS-coronavirus causes 583 disease and mortality in BALB/c mice

Ebola virus persistence in ocular 586 tissues and fluids (EVICT) study: reverse chain reaction and cataract surgery outcomes of Ebola 587 survivors in Sierra Leone

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-590 coronavirus 2. Science

Severe acute respiratory syndrome 594 coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus 595 receptor

Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Clinical characteristics of 138 hospitalized patients with 2019 novel 601 coronavirus-infected pneumonia in Wuhan, China

Coronavirus disease (COVID-2019) situation reports

Cryo-EM structure of the 2019-nCoV spike in the prefusion 606 conformation

Detection of severe acute respiratory syndrome coronavirus in the brain: 609 Potential role of the chemokine mig in pathogenesis

Pathological findings of COVID-19 associated with acute respiratory distress 612 syndrome

Mice transgenic for human angiotensin-converting enzyme 2 provide a 615 model for SARS coronavirus infection

A pneumonia outbreak associated with a new coronavirus of probable 618 bat origin

A novel coronavirus from patients with pneumonia in China

Epidemic trend of corona virus disease 2019 (COVID-19) in mainland 624

Highlights • SARS-CoV-2 could infect HFH4-hACE2 mice and cause death

CoV-2 infection localizes to lungs of mice and causes typical interstitial pneumonia

• Pre-exposure to SARS-CoV-2 protects mice from lethal challenge

CoV-2 hACE2 transgenic mouse infection model recapitulates a number of infection symptoms and pathology in COVID-19 patients. Pre-exposure to SARS-CoV-2 was able to protect mice from severe pneumonia

Further information and requests for resources and reagents should be directed to and will be 400 fulfilled by the Lead Contact, Zheng-Li Shi (zlshi@wh.iov.cn). 401

All materials and reagents generated in this study are available from the Lead Contact with a 403 completed Materials Transfer Agreement. 404

The study did not generate unique datasets or code. 406

The SARS-CoV-2 (IVCAS 6.7512) was isolated using bronchoalveolar lavage fluid sample of 410 patient and was propagated and titrated in Vero E6 cell lines (Zhou et al., 2020 The transgenic mice (HFH4-hACE2 mice) expressing the human ACE2 protein (hACE2) under 419 mixed genetic backgrounds (C3H, C57BL/6) were obtained from Ralph S. Baric's lab 420 (Table S1) . Accidental death or 437 uninfected mice were excluded from subsequent experiments. Infected mice negative for viral 438 RNA in all tissues were regarded as a failed infection. Mice were weighted and observed for 439 clinical signs daily throughout the study. Four to six mice were euthanised at 1, 3, 5 and 7 DPI, 440 and mice presenting more than a twenty percent decrease in body weight were humane 441 euthanised and considered as dead mice. The details regarding the number of male and female 442 mice in each group are shown in Table S1 and Table S4 . Tissues were harvested, including the 443 blood, heart, liver, spleen, lung, brain, kidney, eyes, genital glands, and small intestines. respectively. Tissue sections were rinsed with 1% acetic acid and then dehydrated, cleared, and 494 mounted with neutral gum. The image information was collected using a Pannoramic MIDI 495 system (3DHISTECH, Budapest) and FV1200 confocal microscopy (Olympus and replaced with fresh DMEM containing 2% FBS plus 1% Anti-Anti. CPE was monitored 502 daily, and the supernatant was clarified from debris and subjected to viral RNA extraction after 503 the onset of CPE. Viral RNA copies were quantified by qPCR, and viral antigens were detected 504 using IFA. Images were collected by EVOS M5000 (Thermo). The Next-generation sequencing 505 (NGS) was performed by using Illumina MiSeq 3000 sequencers and the sequences were 506 analysed by Geneious ®10.2.6 for Windows (Zhou et al., 2020) . 507 508

Statistical analyses were performed using PRISM™ 8.0.2 for Windows (GraphPad). Significant 511 differences between groups were determined using a two-way analysis of variance (ANOVA). 512For contrasting two experimental groups, two-tailed Student's t-tests were performed to 513 determine significant differences. Statistical significant: *P < 0.05, ** P <0.01, *** P <0.001, **** 514